Enhancement of Susceptibility to Shiga Toxin-Producing Escherichia coli O157:H7 by Protein Calorie Malnutrition in Mice

Infection and Immunity

Volumn 66, Issue 4, 1998, Pages 1726-1734

  Kurioka, Takaaki ^a   Yunou, Yoshihisa ^a   Kita, Eiji ^a,b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; SHIGA TOXIN;

ANIMAL; ARTICLE; BLOOD; BLOOD CELL COUNT; C57BL MOUSE; CHEMISTRY; DISEASE PREDISPOSITION; ENTEROBACTER INFECTION; FECES; FEMALE; IMMUNOHISTOCHEMISTRY; MICROBIOLOGY; MOUSE; PATHOLOGY; PROTEIN CALORIE MALNUTRITION;

ANIMALS; BACTERIAL TOXINS; BLOOD CELL COUNT; DISEASE SUSCEPTIBILITY; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; PROTEIN-ENERGY MALNUTRITION; SHIGA TOXINS;

EID: 0032038666     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.4.1726-1734.1998     Document Type: Article

References (44)

1. Akashi, S., K. Joh, A. Tsuji, H. Hoshi, T. Hayakawa, J. Ihara, T. Abe, M. Hatori, T. Mori, and T. Nakayama. 1994. A severe outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O157:H7 in Japan. Eur. J. Pediatr. 153:650-655.
2. Al-Jumaili, I., D. A. Burke, S. M. Scotland, H. M. Al-Mardini, and C. O. Record. 1992. A method of enhancing verocytotoxin production by Escherichia coli. FEMS Microbiol. Lett. 93:121-126.
3. Antman, K. H., A. T. Skarin, R. J. Mayer, H. K. Hargreaves, and G. P. Canellos. 1974. Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore) 58:377-384.
4. Babb, T. L., and W. J. Brown. 1987. Pathological finding in epilepsy, p. 511-540. In J. Engl (ed.), Surgical treatment of the epilepsies. Raven Press, New York, N.Y.
5. Barrett, T. J., M. E. Potter, and I. K. Wachsmuth. 1989. Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect. Immun. 57:3434-3437.
6. Chan, J., Y. Tian, K. E. Tanaka, M. S. Tsang, K. Yu, P. Salgame, D. Carroll, Y. Kress, R. Teitelbaum, and B. R. Bloom. 1996. Effects of protein calorie malnutrition on tuberculosis in mice. Proc. Natl. Acad. Sci. USA 93:14857-14861.
7. Cimolai, N., B. J. Morrison, and J. E. Carter. 1992. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic uremic syndrome. Pediatrics 90:616-621.
8. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2253.
9. Francis, D. H., R. A. Moxley, and C. Y. Andraos. 1989. Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7. Infect. Immun. 57:1339-1342.
10. Fujii, J., Y. Kinoshita, T. Kita, A. Higure, T. Takeda, N. Tanaka, and S. Yoshida. 1996. Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect. Immun. 64:5053-5060.
11. Fujii, J., T. Kita, S. Yoshida, T. Kakeda, H. Kobayashi, N. Nakata, K. Ohsato, and Y. Mizuguchi. 1994. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect. Immun. 62:3447-3453.
12. Hamano, S., Y. Nakanishi, T. Nara, T. Seki, T. Ohtani, T. Oishi, K. Joh, T. Oikawa, Y. Muramatsu, Y. Ogawa, and S. Akashi. 1993. Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paediatr. 82:454-458.
13. Jerse, A. E., J. Yu, B. D. Tall, and J. B. Kaper. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effecing lesions on tissue culture cells. Proc. Natl. Acad. Sci. USA 87: 7839-7843.
14. Karmali, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151:775-782.
15. Karmali, M. A., B. T. Steele, M. Petric, and C. Lim. 1983. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet i:619-620.
16. Karpman, D., H. Connell, M. Svensson, F. Scheutz, P. Alm, and C. Svanborg. 1997. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J. Infect. Dis. 175:611-620.
17. Kaye, S. A., C. B. Louise, B. Boyd, C. A. Lingwood, and T. G. Obrig. 1993. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1ß, enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect. Immun. 61:3886-3891.
18. Kita, E., N. Katsui, M. Emoto, Y. Yanagase, and S. Kashiba. 1986. Hepatic lesions in experimental Campylobacter jejuni. J. Gen. Microbiol. 132:3095-3103.
19. Kobayashi, K., K. Seto, and M. Makino. 1990. Detection of two Shiga-like toxins from Escherichia coli O157:H7 isolates by the polymerase chain reaction method. Nippon Saikingaku-Zasshi (Jpn. J. Bacteriol.) 45:649-652.
20. Koster, F., J. Levin, L. Walker, K. S. K. Tung, R. H. Gilman, M. Rahaman, A, Mjid, S. Islam, and R. C. Williams. 1978. Hemolytic uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N. Engl. J. Med. 298:927-933.
21. Kurioka, T., et al. Unpublished data.
22. Levine, M. M., J. G. Xu, J. B. Kaper, H. Lior, V. Prado, B. Tall, J. Nataro, H. Karch, and I. K. Wachsmuth. 1987. A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J. Infect. Dis. 156:175-182.
23. Lingwood, C. A., H. Law, S. Richardson, M. Petric, J. L. Brunton, S. De-Grandis, and M. A. Karmali. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262: 8834-8839.
24. Louise, C. B., and T. G. Obrig. 1991. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1β, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59:4173-1179.
25. Louise, C. B., and T. G. Obrig. 1992. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Immun. 60: 1536-1543.
26. Morrison, D. M., D. L. J. Tyrrell, and L. D. Jewell. 1986. Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP). Am. J. Clin. Pathol. 86:108-112.
27. Myhal, M. L., D. C. Laux, and P. S. Cohen. 1982. Relative colonizing abilities of human fecal and K-12 strains of Escherichia coli in the large intestines of streptomycin-treated mice. Eur. J. Clin. Microbiol. 1:186-192.
28. Neild, G. H. 1994. Haemolytic-uraemic syndrome in practice. Lancet 343: 398-401.
29. Noda, M., T. Yutsudo, N. Nakabayashi, T. Hirayama, and Y. Takeda. 1987. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb. Pathog. 2: 339-349.
30. O'Brien, A. D., and R. K. Holmes. 1987. Shiga and Shiga-like toxins. Microbiol. Rev. 51:206-220.
31. Ohkura, K. (Department of Pediatrics, Kobe Municipal Hospital, Kobe, Japan). Personal communication.
32. Richardson, S. E., T. A. Rotman, V. Jay, C. R. Smith, L. E. Becker, M. Petric, N. F. Olivieri, and M. A. Karmali. 1992. Experimental verocytotoxemia in rabbits. Infect. Immun. 60:4154-4167.
33. Riley, L. W., R, S. Remis, S. D. Helegerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
34. Scotland, S. M., H. R. Smith, and B. Rowe. 1985. Two distinct toxin active on Vero cells from Escherichia coli. Lancet ii:885-886.
35. 1. Cur. Microbiol. 25:215-217.
36. Strockbine, N. A., L. R. M. Marques, J. W. Newland, H. W. Smith, R. K. Holmes, and A. D. O'Brien. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
37. Thomas, A., H. R. Smith, G. A. Willshaw, and B. Rowe. 1990. Non radioactively labelled polynucleotide and oligonucleotide DNA probes for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2, and VT2 variant. Mol. Cell Probes 5:129-135.
38. Tzipori, S., C. W. Chow, and H. R. Powell. 1988. Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets. J. Clin. Pathol. 41:1099-1103.
39. Upadhyaya, K., K. Barwick, M. Fishaut, M. Kashgarian, and N. J. Siegel. 1980. The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 65:115-120.
40. Valavaara, R., and E. Nordman. 1985. Renal complication of mitomycin C therapy with special reference to the total dose. Cancer 55:47-50.
41. Waddell, T., S. Head, M. Petric, A. Cohen, and C. Lingwood. 1988. Globotriosyl ceramide is specifically recognized by the Escherichia coli verotoxin 2. Biochem. Biophys. Res. Commun. 152:674-679.
42. Wadolkowski, E. A., L. M. Sung, J. A. Burris, J. E. Samuel, and A. D. O'Brien. 1990. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect. Immun. 58:3959-3964.
43. Willshaw, G. A., H. R. Smith, S. M. Scotland, and B. Rowe. 1985. Cloning of genes determining the production of Vero cytotoxicity by Escherichia coli. J. Gen. Microbiol. 131:3047-3053.
44. Yamai, S., Y. Obara, T. Nikkawa, Y. Shimoda, and Y. Miyamoto. 1979. Preservation of Neisseria gonorrhoeae by the gelatin-disc method. Br. J. Vener. Dis. 55:90-93.